Clinical Trials

NCT05585775 | ACTIVE_NOT_RECRUITING | NA
76 participants

Mood and Thought Process Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2023-04-06
Completion:
2026-12-31
Conditions
  • Depression in Remission
  • Depressive Symptoms
  • Depression
Interventions
  • BEHAVIORAL
No Results Yet
NCT05583864 | ACTIVE_NOT_RECRUITING | NA
108 participants

Lumbar Fusion With Porous Versus Non-Porous Cages

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2022-11-01
Completion:
2026-06-10
Conditions
  • Spinal Fusion
  • Lumbar Fusion
  • Arthrodesis
  • Spondylolisthesis
  • Pseudarthrosis
Interventions
  • DEVICE
No Results Yet
NCT05434572 | RECRUITING
500 participants

CIMR Neuromuscular Research Biobank

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-06
Start Date:
2021-03-17
Completion:
2030-01-31
Conditions
  • Neuromuscular Diseases
  • Neuromuscular Disorder
  • Neuromuscular Diseases in Children
No Results Yet
NCT05378347 | RECRUITING | NA
600 participants

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2023-01-05
Completion:
2027-05-31
Conditions
  • Abdominal Aortic Aneurysm
  • Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
  • Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Interventions
  • DEVICE
No Results Yet
NCT05348876 | RECRUITING | PHASE4
50 participants

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2022-08-03
Completion:
2027-04-29
Conditions
  • Non-metastatic Castration-resistant Prostate Cancer
Interventions
  • DRUG
No Results Yet
NCT05230524 | TERMINATED
84 participants

DIAMOND AF Post-Approval Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-06
Start Date:
2022-02-28
Completion:
2025-12-17
Conditions
  • Paroxysmal Atrial Fibrillation
Interventions
  • DEVICE
No Results Yet
NCT05139004 | ACTIVE_NOT_RECRUITING | PHASE1
7 participants

90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2022-07-19
Completion:
2027-06-13
Conditions
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Secondary Acute Myeloid Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page